There is evidence to show that growth is slowly becoming inclusive. But for the quality of life to improve, incomes must be complemented by infrastructure. For close to at least five years now inclusive growth has had a central place in the official discourse on the economy. The UPA II has itself worn its self-proclaimed success in delivering an inclusive growth as a badge of its effectiveness, not to mention its...
More »SEARCH RESULT
Anti-scavenging law only on paper-Ananya Sengupta
Not a single case has been registered under a 19-year-old law that prohibits hiring of manual scavengers and building dry latrines. The revelations come weeks after the latest census data showed 25 lakh households across the country depend on manual scavengers to remove night soil from latrines. Union social justice minister Mukul Wasnik conceded implementing the Employment of Manual Scavengers and Construction of Dry Latrine (Prohibition) Act, 1993, had been “weak”. “The implementation...
More »Posco in limbo-V Venkatesan
The National Green Tribunal's decision to suspend the environmental clearance given to Posco vindicates the project's critics. ON March 30, the Principal Bench of the newly formed National Green Tribunal (NGT) delivered a momentous decision suspending the environmental clearance (EC) given to the South Korean transnational corporation, Posco, to set up an integrated steel plant at Paradip in Odisha's Jagatsinghpur district. The former Union Minister for Environment and Forests, Jairam...
More »Western warnings-R Ramachandran
India is coming under increasing pressure from the U.S. and the European Union for the strict patentability criteria it applies for medicines. AS was only to be expected, the two landmark decisions made by the Indian patent office in recent times concerning pharmaceutical patent cases have not gone down well with the multinational drug industry. First, there was the rejection in 2006 of the patent application by the Swiss multinational...
More »Drug approvals fall on account of tardy & tedious process by NDAC-Divya Rajagopal
Confusion sparked by the setting up of a new committee for drug approvals has led to a slide in the number of new medicines getting cleared even as millions of Indians struggle with diabetes and heart failures remain a major killer. The Drug Controller General of India (DCGI) has shed its role as the sole approver of new drugs in the country after a new committee, set up by the health...
More »